Articles by Park Min-ha
Park Min-ha
-
Coupang hosts global hackathon to seek innovative solutions
E-commerce giant Coupang announced Monday the company became the first domestic distributor to co-host a global hackathon event. Dubbed as "Hackseoul," the event, held on Saturday and Sunday, brought together some 200 software developers from 10 countries, including the US, Canada, Uzbekistan and India, at the company's headquarters in Songpa-gu, Seoul. AngelHack, a US-based company that has organized numerous hackathon events since 2011, designed the overall contest. The event wa
Industry Aug. 26, 2024
-
Dongsuh enhances marketing strategy for instant coffee leadership
Korean food and beverage manufacturer Dongsuh Foods said Sunday it is ramping up marketing efforts to retain its unrivaled leadership in the nation’s instant coffee market. The company has topped instant coffee sales over the last three decades with its flagship Maxim Mocha brand. More recently, it has been diversifying its marketing strategy to appeal to a wide range of consumer groups and further boost sales of its best-selling products. Dongsuh has operated its flagship store, called Ma
Industry Aug. 25, 2024
-
Seomjae applies for patents for AI-based learning system
Seomjae, a Seoul-based education solutions developer, announced Thursday that the company applied for three patents for its AI-based learning system earlier this month. One of the patents is an AI technology that automatically analyzes and summarizes online lectures and captures lecturers’ characteristics using a neural network system. The technology can offer personalized data to its users by systematically summarizing lecture content and carrying out an in-depth analysis of the lecturers
Industry Aug. 22, 2024
-
Coway outpaces rivals in filter technology
Korean home appliance-maker Coway has retained its No. 1 position in the nation’s water purifier market for almost three decades with its unrivaled filter technology. “Since the very beginning of our water purifier business, we have put intensive effort into enhancing the quality of water filters, one of the key components. Unlike most competitors, we can produce the products' main water filters on our own,” said a company official. With constant efforts to enhance the qua
Industry Aug. 22, 2024
-
LG Innotek taps global talent to spur growth
LG Innotek, the advanced materials and components maker affiliated with LG Group, is speeding up efforts to recruit outstanding international students to enhance its global competitiveness. According to the company on Wednesday, a total of 31 international students either from foreign or Korean universities joined this year’s global internship program that was completed earlier this month. Under the five-week program, the students were allocated to diverse business divisions, including res
Industry Aug. 21, 2024
-
Daewoo E&C builds good management-labor relationship
Daewoo Engineering & Construction and its labor union have joined hands in the effort to create positive, amicable workplace culture for all workers and break through market challenges together. According to the South Korean builder on Tuesday, the management and union reached an agreement earlier this month to reform the company's personnel management systems. The plan includes simplifying the ranking system and upgrading personnel evaluation and wage schemes. They also completed this
Companies Aug. 20, 2024
-
Daewoong’s botulinum toxin debuts in Australia
Daewoong Pharmaceutical, South Korea’s leading drug maker, announced Monday the company officially launched its botulinum toxin, dubbed Nuceiva, in Australia in partnership with a Nasdaq-listed US company Evolus. Oceania is the fifth continent Daewoo Pharmaceutical has entered, after North America, South America, Europe and Asia, with its self-developed botulinum toxin. “Our market penetration into Australia will allow us to build on the momentum of expanding presence in the global m
Industry Aug. 19, 2024
-
NeuroBo Pharmaceuticals completes patient enrollment for phase 1 trial for antiobesity drug
NeuroBo Pharmaceuticals, the Nasdaq-listed biotech firm affiliated with South Korean drug maker DongA ST, announced Wednesday the company has completed patient enrollment for the first part of the phase 1 clinical trial for its antiobesity drug, dubbed DA-1726. DA-1726, designed to induce weight loss and glycemic control by simultaneously affecting GLP-1 and the glucagon receptor, is a drug candidate for treating obesity developed as an oxyntomodulin analog. In January, NeuroBo Pharmaceuticals
Industry Aug. 16, 2024
Most Popular
-
1
Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child
-
2
Wealthy parents ditch Korean passports to get kids into international school
-
3
Man convicted after binge eating to avoid military service
-
4
First snow to fall in Seoul on Wednesday
-
5
Final push to forge UN treaty on plastic pollution set to begin in Busan
-
6
Korea to hold own memorial for forced labor victims, boycotting Japan’s
-
7
Nvidia CEO signals Samsung’s imminent shipment of AI chips
-
8
Job creation lowest on record among under-30s
-
9
NK troops disguised as 'indigenous' people in Far East for combat against Ukraine: report
-
10
Opposition leader awaits perjury trial ruling